Cognitive Behavioural Therapy (CBT) is a form of evidence-based talking therapy that emphasises the importance of behaviour and conscious thoughts in shaping our emotional experiences. As pain becomes increasingly accepted as not only a sensory but also an emotional experience, success in using CBT to treat emotional disorders has resulted in the incorporation of cognitive-behavioural principles into the management of chronic pain. Outcomes of CBT-informed interdisciplinary pain management programmes are modest at best, despite rapid methodological improvements in trial design and implementation. Whilst the field searches for new treatment directions, a hybrid CBT approach that seeks to simultaneously tackle pain and its comorbidities shows promise in optimising treatment effectiveness and flexibility. This article provides a brief description of the core characteristics of CBT and the transformation this therapeutic model has brought to our understanding and management of chronic pain. Current evidence on efficacy of CBT for chronic pain is then reviewed, followed by a critical consideration of the advantages and disadvantages of the new hybrid treatment approach that conceptualises and treats chronic pain in connection with its comorbidities. Recent progress made in the area of pain and insomnia is highlighted as an example to project therapeutic innovations in the near future.
. CBT stands for a form of talking therapy that emphasises the importance of both behaviour and conscious thoughts in shaping our emotional experiences (Beck, 1976 (Beck, , 2011 Hawton et al., 1989; Clark and Fairburn, 1997) . Its theoretical foundation extends from the purely behavioural learning principles (e.g., classical and operant conditioning), to incorporate cognitive factors (e.g., beliefs and attribution) in recognition of their roles in influencing our behaviour, affecting how we feel, and even shaping our physiological responses.
Typically, psychological interventions that draw on both behavioural principles and cognitive science -regardless of the extent -are collectively referred to as CBT. Hence, CBT is an umbrella term that includes treatments of different foci, contents, designs, length and interface. Several key features should, however, be recognisable even across different permutations of CBT (Hawton et al., 1989) . First, in contrast to psychodynamic approaches, CBT focuses on the conscious experience and the here-and-now. The aim of the treatment is to help the patient bring about adaptive learning and desirable changes in their present lives, not their distant past. And so relatedly, second, the treatment content of CBT is goal-driven; and duration time-limited. Third, a large part of the treatment is about problem-solving and acquisition of new coping skills. Consolidation of learning between treatment sessions in the form of an exercise or a homework assignment is important, as these are the tools to help the patient apply and generalise their new skills to contexts outside of the therapy setting. The ultimate goal is to enable the patient to become their own therapist, and hence, fourth, the therapeutic relationship shared between the CBT therapist and the patient is collaborative and supportive, rather than hierarchical and directive. Finally, in keeping with the tradition of scientific investigation of human behaviour and cognition, CBT as a field places strong emphasis on defining concepts in measurable terms and putting treatment programmes under the scrutiny of empirical evaluation, ranging from single-case experiments to multi-centre randomised controlled trials. Such tradition lays the foundation of the evidence-based nature of CBT; and the corresponding training of CBT delivery can be distinguished from that for non-directive counselling, which puts heavier emphasis on conversation and empowerment within a social and cultural context and lighter emphasis on symptom reduction and treatment process and outcome evaluation.
The emergence of CBT was originally embedded within the growing need to address common emotional disturbances such as anxiety and depression (Beck, 1976; Ellis, 1989 Ellis, , 1962 but its influence soon spread and led to successful applications in the understanding and treatment of a range of difficult-to-treat psychiatric and medical disorders. These include panic disorder, obsessive-compulsive disorder, posttraumatic disorder, health anxiety, eating disorders, insomnia disorder, schizophrenia, and suicide. Chronic pain is a prevalent, disabling condition affecting 19% of the general population in Europe (Breivik et al., 2006) and as many as 31% of the adult population in the US (Johannes et al., 2010) . It is one of the areas that has benefited from the application of CBT principles for the understanding and management the condition. Below I will illustrate the emergence of CBT for chronic pain, beginning with a brief overview of the development in pain conceptualisation that has led to the application of interventions based on cognitivebehavioural principles and further work in evaluating the efficacy of CBT pain management programmes.
CBT in pain

Theoretical developments
Pain was once thought to be a strictly biological phenomenon that is specifically and proportionally linked to tissue damage or an underlying pathology. However, a shift in thinking was marked by the introduction of the groundbreaking Gate Control Theory (Melzack and Wall, 1965) , which attempts to explain well-documented anomalies that deviate from previous conceptualisations of pain, such as the highly variable relationship between injury and pain, whereby innocuous stimuli may produce pain and that pain may persist or even spread in the absence of injury or after an extensive period of healing. In layman's terms, the Gate Control Theory describes how nerve impulses enter the spinal cord and travel to the brain for interpretation as pain. Transmission of the signals can go in both the top-down and bottom-up directions, and a gating mechanism in the dorsal horn of the spinal cord functions to modulate the signals, such that whilst the balance of the small and large fibre activities in the spinal cord can facilitate (i.e., open the gate) or inhibit (i.e., close the gate) the afferent signals, the brain can send descending signals to modulate the transmission, exerting central control.
Although the premises of the Gate Control Theory are fundamentally physiological, the theory offers a readily acceptable grounding for psychological explanations of variations in pain responses to flourish. In contrast to nociception, pain was subsequently recognised as a "psychological state", when the International Association for the Study of Pain (IASP) put forward a taxonomical definition of pain as "an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage" (Merskey and Bogduk, 1979) . The IASP definition brings to the fore that pain is not just a sensory but also an emotional experience, subject to psychological influence.
The shift away from the strictly physiological approach to pain has permitted the application of behavioural and cognitive principles for the study and management of pain. This was spearheaded by the work of Fordyce (1976a,b) who detailed how adaptive acute pain behaviour (e.g., grimace, moaning, limping, avoidance of activity, increased use of anagelsics) is reinforced and maintained to become maladaptive and chronic by positive and negative reinforcement, in line with the generic operant conditioning model. Accordingly, it was suggested that chronic pain is best treated as a set of illness behaviour and the intervention should be focused on modifying the environment contingencies that elicit the pain behaviour, with a goal to reduce their frequency of occurrence and hence the associated disability (Fordyce et al., 1982) .
Subsequent research into the effect of cognition (pain catastrophising, pain anticipation, pain memory) and affect (anxiety, depression) on pain perception and coping has led to the incorporation of a cognitive dimension into the primarily behavioural approach to chronic pain (Turk et al., 1983) . Several iterations of the fearavoidance model of chronic pain have been proposed to explain how different interpretations of the same pain experience could determine whether a person would confront the pain and be on the road of recovery, or display the chronic pain behaviour that would eventually lead to disuse, depression and disability Slade et al., 1983; Philips, 1987; Vlaeyen et al., 1995; Asmundson and Taylor, 1996; Vlaeyen and Linton, 2000; Asmundson et al., 2004) . There are subtle differences in the emphasis of each iteration of the fear-avoidance model, but the key cognitive factors at play are the interpretation and meaning people ascribe to the pain experience. In the absence of serious pathology, if the pain is considered unpleasant but non-threatening, then the person would perhaps restrict pain-provoking activity in the short term but gradually return to their prior level of activity as the injury heals up and pain dissipates. However, if pain is given a catastrophic meaning suggesting harm or threats to body integrity, the catastrophic meanings ascribed to the pain will give rise to pain-related fear, motivating hypervigilance (such as excessive threat-monitoring behaviour) and behavioural avoidance (of daily activities that may induce or aggravate pain) in the long term (Fig. 1a) . Such conceptualisation of chronic pain and its associated distress and disability brings the theoretical development closer to the Beckian approach to CBT (Fig. 1b) and the generic model of anxiety disorders (Fig. 1c) . Subsequent modifications to the model to consider the influence of negative affectivity, physiological arousal, and the role of threatening illness information expand the horizon of the examination to align more closely with the multidimensional perspective of pain and the PPP (predisposing, precipitating and perpetuating factors) case formulation framework (Asmundson et al., 2004) .
Treatment implications
Given that avoidant behaviour and catastrophising are hypothesised to be key interacting mechanisms underpinning the development and maintenance of disability and disuse in chronic pain, a therapeutic intervention derived from the fear-avoidance model is graded exposure to movements and activities feared by the patient. In contrast to graded activity that aims to increase the total amount of physical activity, the idea behind graded exposure in vivo is to afford the patient the opportunity to confront their fear. Through engaging in a series of behavioural experiments (Bennett-Levy et al., 2004) , the patient is also helped to disconfirm or soften prior expectations and catastrophic beliefs that movements will cause (re)injury and further suffering. Typically, the design of the exposure procedure is personalised to the patient's individual fear hierarchy such that patients are first exposed to activities associated with mild to moderate levels of fear before confronting activities that provoke high levels of fear (Vlaeyen et al., 2001 (Vlaeyen et al., , 2002a Leeuw et al., 2007) . Several high-quality single case series and randomised controlled trials have demonstrated the effectiveness of graded exposure over and above psycho-education or graded activity in patients with chronic low back pain (Vlaeyen et al., 2001 (Vlaeyen et al., , 2002b de Jong et al., 2005a; Boersma et al., 2004; Woods and Asmundson, 2008; Leeuw et al., 2008) , neck pain patients (de Jong et al., , 2012 , and complex regional pain syndrome (de Jong et al., 2005b) , with concurrent reductions in pain-related fear, pain catastrophising and painrelated disability. The results also appeared to maintain well up to 6 months after treatment.
Graded exposure in vivo, however, is not the sole intervention received by chronic pain patients, as psychological treatments tend to be delivered as part of an interdisciplinary pain management programme within specialist pain clinics (Gatchel et al., 2014; The British Pain Society, 2013) . Within such a context, CBT for chronic pain is much more broadly defined as an amalgamation of interventions that may vary in approach and emphasis (Behaviour Therapy, Cognitive Therapy, Cognitive-Behavioural Therapy, Acceptance Commitment Therapy), format (individual vs. group; outpatient vs. inpatient; face-to-face vs. telemedicine/online), and dosage (amount of input at different frequency and levels of intensity) depending on the availability of resources and expertise. The theoretical principle and evidence-base of these other treatment components, arguably, are not always as well documented as graded exposure.
Nonetheless, the central goal of most pain management programmes based on cognitive-behavioural principles is to help patients better manage problems evolved around maladaptive emotions, cognition and behaviour, rather than focusing on pain elimination. Like CBT for depression and anxiety, main components of CBT for chronic pain include first and foremost psycho-education, which involves educating the patients about the rationale of the treatment and the impact of cognition and behaviour on their emotions and pain experience. Once a shared understanding of the CBT model of chronic pain is established, the patients will be taken through a journey of coping skills training ranging from relaxation, physical exercise, pacing, to communication skills training. The idea is that during the course of the treatment, the patients are helped to apply these skills in day-to-day situations and maintain these skills as they are practised in real life. Patients are also taught how to cope with relapse and flare-ups, in the hopes that they will become their own therapists when the therapeutic engagement comes to an end. Table 1 below outlines the aims and methods of several common CBT components often included in interdisciplinary pain management programmes.
Efficacy of CBT for chronic pain
Notwithstanding the known heterogeneity in treatment content, CBT for chronic pain has typically been evaluated for its efficacy as an overall package in a number of RCTs. A comprehensive Cochrane Review by Eccleston et al. (2009) has provided an excellent overview of the efficacy of CBT for the management of chronic pain in general, except headache, among adult patients. Specifically, the systematic review included 24 meta-analyses based on data pooled from 40 RCTs, published before Jan 2008 involving 4781 participants (Mean age = 48.7 yrs.; Median pain duration: 9.9 yrs). The purpose of the analyses was to examine the effect of BT and CBT versus passive or active treatment control interventions on pain, disability, and mood at posttreatment and at follow-up (6-12 months after treatment). In these analyses, passive treatment control interventions referred to control procedures in RCTs that were labelled as "waiting list control" or "treatment as usual". Active treatment control interventions were those that involved a protocolised treatment that engaged the patients, e.g., a self-help booklet, a support group, an exercise class, an educational programme, or a medical procedure. Of the 6 outcome comparisons made for CBT against passive treatment control interventions, 2 revealed a significant effect showing that CBT had a small effect on pain included was assessed qualitatively using the 'high', 'unclear' and 'low 'risk traffic light system and quantitatively using the Yates et al. (2005) scale. Qualitatively, the majority of the studies were considered to have 'adequate' study (65.4%), treatment (53.8%) and design (61.5%) quality. Quantitatively, the mean overall quality of the studies was 19.3 (Standard Deviation = 4.8; Range = 9-28). The mean design quality score was 14.4 (SD = 3.7; Range = 7-23) and the mean treatment quality score was 4.9 (SD = 2.2; Range = 1-8).
As the number of RCTs of CBT for chronic pain has rapidly increased in a short space of time, Williams et al. (2012) provided an update to the 2009 review involving 35 RCTs of 4788 participants published before September 2011. This review had similar but slightly more stringent inclusion criteria, raising the bar of entry from 10 to 20 participants in each treatment arm. This decision was to minimise potential risk of bias associated with trials of small sample size and to address the overall tendency for smaller or poor-quality trials to produce more positive results (Ioannidis, 2005; Furlan et al., 2001; Nüesch et al., 2009) . A total of 65 trials were identified and 42 met inclusion criteria, of which 16 were new entries since the 2009 review and 35 of these trials provided data for the meta-analysis. The included studies showed an improvement in their overall methodological quality as expected. Using the same method of comparisons, the pattern of findings was broadly similar to those shown in the 2009 review (see Fig. 2a & b) . Although the longer term effect on pain and mood found for CBT against active treatment control interventions no longer upheld at follow up, the effects of CBT against passive treatment control interventions were noticeably more consistent and appeared to be stronger across all 3 major outcome measures.
Based on both sets of review, the authors concluded that there was a sufficiently large evidence base to show that CBT had a small to moderate beneficial effect on key outcome measures of importance to chronic pain, particularly at immediately after treatment and when compared to passive control interventions. The magnitude of the effect was not as big as hoped, but may accurately reflect the true extent of "complexity of behaviour change and the social and psychological influences that maintain disability in chronic pain patients" (Blyth et al., 2007) . Whilst there are many theoretical and practical issues remain to be addressed to move the field forward (see discussion of Williams et al., 2012 for an insightful analysis), CBT can be useful in reducing pain, disability and psychological distress, in par with other established drug and physical treatments for chronic pain (Hellum et al., 2011; Fairbank et al., 2005) .
Challenges beyond perfecting RCT methodology
Interested readers are referred to Williams et al. (2012) , Morley et al. (2013) , Eccleston (2013) , for a detailed analysis on the theoretical and practical issues remained to be addressed by the field. Two additional challenges are highlighted below, as we consider the connections between CBT for chronic pain and CBT for other psychological disorders.
First, despite the more consistent effect of CBT, the magnitude of the controlled effect size is small according to Cohen's interpretation (1992) as well as relative to what can be achieved in CBT for other common emotional disorders (Butler et al., 2006) , as summarised in Table 2 . Using mood -the most favourable outcome measure in the 2012 Cochrane review -for example, the maximum effect size was 0.38 immediately after treatment but attenuated to 0.26 at follow-up. These statistics mean that a person randomly drawn from the CBT group has only a 61% chance of being better off than a person randomly drawn from the passive control group (i.e., the probability of benefit) when the comparison is made at post-treatment; the probability of benefit reduces to 57% when the comparison is made at 6-to 12-month followup. The deficits in effect size and probability of benefit evident in Table 2 raise the question that, perhaps, the field is far from maximising the potential of CBT for the management of chronic pain. It is also noted that, for 2 of the 3 key outcome measures (i.e., pain intensity and disability), the effect of CBT for chronic pain did not sustain at follow-up as it would normally be expected for CBT for common emotional disorders. This is surprising given the heavy skills learning component in various pain management packages. Second, the overwhelming majority of the chronic pain patients seen in day-to-day clinical practice are presented with some kind of physical or psychological comorbidity (Arnow et al., 2006; Knaster et al., 2012) . More often than not, those reporting comorbid issues are also those who reported more severe pain, greater disability, and poorer quality of life (Bair et al., 2008) . Outside of the clinical setting, Von Korff et al. (2005) estimated that 87% of the general population living with chronic spinal pain also reported at least 1 other mental disorder, chronic physical diagnosis, and/or other chronic pain conditions. Importantly, the presence of these comorbidities explained approximately a third of the association between chronic pain and disability. Similar findings were reported by McWilliams et al. (2003) focusing on the co-occurrence of chronic pain with psychiatric disorders. Significant cross-sectional associations were observed between chronic pain and mood and anxiety disorders (odds ratios = 1.92-4.27), with the strongest associations being found for panic disorder (OR = 4.27) and posttraumatic stress disorder (OR = 3.69). Additionally, the presence of more than one comorbid psychiatric disorders was significantly linked to increased disability. Together, these findings converge to suggest that the purely pain-focused treatment approach may be inadequate for tackling the complex psychological issues experienced by chronic pain patients, which could be simultaneously be maintained by the pain and the co-existing comorbid physical and psychiatric conditions. A radical reconceptualisation of our treatment approach to chronic pain is warranted if we were to break through the treatment effect size ceiling and to improve the quality of care to become more patient-centred, rather than diagnosis-focused.
A hybrid approach
A hybrid approach to the treatment of chronic pain is an exciting new direction, whereby the treatment is developed and applied to simultaneously address multiple issues linked to chronic pain rather than exclusively focusing in on pain management or reduction (Tang, 2009; Tang et al., 2012a Tang et al., , 2008 . The concept represents a departure from the conventional practice that confines the matching of interventions to well-defined diagnostic labels. It explicitly acknowledges that complex conditions, such as chronic pain, do not exist in isolation, but interacts with co-occurring physical and mental comorbidities that may in return impact on pain management.
Advantages
By adopting a broader conceptualisation of the distress and disability experienced by chronic pain, the hybrid approach gives clinicians the flexibility to draw up treatment and rehabilitation plans based on individual case formulations rather than relying on predetermined protocolised treatment packages. It also facilitates better customisation of treatment, an action point that has been called for by multiple leaders of the field (Gatchel et al., 2014; Eccleston et al., 2009; Williams et al., 2012; Morley et al., 2013; Turk et al., 2010) .
The hybrid treatment approach is arguably a more appropriate strategy for managing chronic pain, which by definition is intractable. Simultaneous efforts targeting common comorbidities offer new treatment Table 2 Magnitude of effect size (ES) and probability of benefit (PB) achieved by CBT for other psychological disorders.
Post-treatment ES (vs. passive controls)
Probability of benefit (in the CBT group) Post-treatment ES (vs. active controls) Probability of benefit (in the CBT group) Adult depression (Gloaguen et al., 1998) Notes. Absolute controlled effect sizes (ES) achieved on key index symptoms across 5 common emotional disorders are reported in SMD/Cohen's d, based on meta-analyses reviewed in Butler et al., 2006 . Effect size is small, SMD = 0.2; medium, SMD = 0.5; and large, SMD = 0.8 (Cohen, 1992) Probability of benefit (PB) = Probability that a person from the CBT group will be better off after treatment than a person from control, if both are chosen at random. It is calculated using the formula, PB ¼ Φ ð Y1−Y2 ffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi entry points to break unhelpful patterns of pain-related cognition and behaviour that give rise to the distress and disability. Instead of fixating on managing pain, a hybrid approach diversifies the treatment goal, allowing the patient to reframe their relationship with pain and offering the opportunity to move away from pain control and to focus their efforts on addressing other issues affecting quality of life and on attaining more achievable goals (Eccleston and Crombez, 2007) . It also opens up possibilities of introducing treatment components that target transdiagnostic processes, e.g., hypervigilance, worry, catastrophising, appraisal biases, avoidance, safety-seeking behaviour, and thoughtsuppression (Harvey, 2004; Fairburn et al., 2003; Cappuccio et al., 2010) . The result of these changes may streamline the process of imparting core coping skills that are essential for wellbeing and optimal functioning, especially within the modern healthcare eco-system where time and resources are limited. Practically, the hybrid approach downplays the importance of establishing the 'primary' and 'secondary' hierarchy of co-occurring disorders and helps to bypass the artificial boundary between physical and mental health. This is in line with shifts in thinking around comorbidities management (van Weel and Schellevis, 2006; Starfield et al., 2003; Linton, 2013) and can serve to simplify the navigation through complex health care pathways by offering treatment of multiple problems under one roof and reducing the number of contact points. It may also help to avoid situations in which patients are stuck in gaps between physical and mental health care services. It is not uncommon to hear of accounts of treatment seeking experience in which patients found themselves refused treatment by mental health services because the psychological symptoms were considered to be 'caused' by pain (thus the patient 'should' be seen by pain specialists), or by pain management services because the psychological symptoms are thought to be too severe impacting on pain management efforts (and hence specialist psychological input 'should' be received first, before the patient is re-referred to the pain service for rehabilitation).
Recent development in pain and insomnia as an example
Although the overlaps between pain and anxiety (McWilliams et al., 2003; Asmundson and Katz, 2009 ) and between pain and depression (Banks and Kerns, 1996; Romano and Turner, 1985; Fishbain et al., 1997) are better recognised, the co-occurrence of pain and sleep has received more attention in recent years and witnessed a surge in research efforts in understanding the nature of comorbidity and in developing specific hybrid treatments for improving treatment efficacy and patient outcomes (Tang, 2009; Smith and Haythornthwaite, 2004; Finan et al., 2013; Moldofsky, 2001; Lavigne et al., 2010) . The co-existing problem of sleep and pain is widespread. In the general population, around two-thirds of individuals living with chronic pain report a reduced ability to sleep because of their pain (Breivik et al., 2006) . At the more severe end of the spectrum, it has been estimated that between 50 and 90% of patients seeking treatment from hospital pain clinics report insomnia of a severity that warrants clinical attention (Atkinson et al., 1988; Tang et al., 2007a; McCracken et al., 2011) . Further, it is understood that chronic pain patients who experience insomnia are also those who report higher pain intensity, anxiety, depression, physical and psychosocial disability (Breivik et al., 2006; Chiu et al., 2005; McCracken and Iverson, 2002; Morin et al., 1998; Nicassio et al., 2002; Pilowsky et al., 1985; Smith et al., 2000; Wilson et al., 1998; Haythornthwaite et al., 1991) . Left untreated, the majority of the insomnia cases would persist (Morphy et al., 2007) continuing to undermine efforts of pain management and compound the level of pain, distress and disability. Such detrimental effect is observed both on a day-today basis (Affleck et al., 1996; Tang et al., 2012b; Tang and Sanborn, 2014; Edwards et al., 2008; Lewandowski et al., 2010) and over longer periods (Campbell et al., 2013) .
The development of hybrid treatments for chronic pain and insomnia is only in its infancy, but it is certainly a movement gaining momentum at a time when the term 'secondary insomnia' is being phased out (NIH, 2005) and epidemiological evidence is accumulating to show that sleep is a risk factor and a potential cause of a range of physical and mental illnesses, directly and indirectly increasing the risk of mortality (Cappuccio et al., 2011) . The momentum is also bolstered by demands from the pain patients themselves, explicitly stating the negative impact on pain management when they are not sleeping well Tang et al., 2009 ) and indicating that their wish to receive more support and help in obtaining better sleep (Breivik et al., 2006; Turk et al., 2008a; Casarett et al., 2001) . These patient demands make a lot of sense, as increasing evidence has shown that sleep disruption can aggravate pro-inflammatory responses, amplify pain experience, weaken endogenous pain inhibitory control, reduce pain tolerance, and increase bodily symptoms (Haack and Mullington, 2005; Irwin et al., 2012; Moldofsky and Scarisbrick, 1976; Smith et al., 2007) .
Yet, sleep thus far is not a main focus of many existing pain management programmes, although standard sleep hygiene advice -which is not considered as an effective stand-alone treatment for insomnia (Morin et al., 1999; Morgenthaler et al., 2006) -is usually given to patients as part of the psychoeducation component of the intervention. Naturally, sleep is not a major outcome measure when evaluating the impact of these pain management programmes. Of the few trials that do measure sleep pre-and post-treatment, a couple of studies have demonstrated that sleep does not necessarily improve after completion of a course of CBT for pain, even when improvements are found for pain coping skills and pain-related functional outcomes (Redondo et al., 2004; Gustavsson and von Koch, 2006) . A couple others have shown a slight improvement in subjective ratings of sleep, but "against a backdrop of poor patterns of night time sleep" with no improvement in key quantitative sleep efficiency and quantity parameters (Becker et al., 2000; Ashworth et al., 2008) . In contrast, a series of RCTs evaluating the application of CBT for insomnia (CBT-I) in chronic pain patients have shown promise (Tang, 2009; Currie et al., 2000; Edinger et al., 2005) . As summarised in a recent meta-analysis involving 11 RCTS involving 1066 patients, psychological sleep treatments in chronic pain patients are associated with not only improvement in sleep quality; significant improvements were also found for pain and fatigue at posttreatment and for fatigue and depression at follow-up up to 12 months (Tang et al., 2015) .
Capitalising on these promises, in the last 5 years or so at least three different groups in the US and the UK have independently published initial findings evaluating the feasibility and utility of hybrid treatments for chronic pain and comorbid insomnia. Two pilot RCTs were conducted with mixed groups of chronic pain patients recruited from secondary care (Tang et al., 2012a; Pigeon et al., 2012) and one multi-centre 3-arm RCT was tested with older osteoarthritis patients from primary care (Von Korff et al., 2012; Vitiello et al., 2013 Vitiello et al., , 2014 . The timing of these publications clusters around the same time, reflecting a consensus that 'going hybrid' may be a promising direction for future treatment development.
There are variations between these hybrid treatment programmes in term of the selection of treatment components. The hybrid treatment in Tang et al. (2012a) was designed to target cognitive-behavioural processes maintaining chronic pain and insomnia. The weekly treatment was delivered by psychologist on a one-to-one basis over 4 weeks. The selection of treatment components was informed by existing treatment manuals (Carney and Edinger, 2008; Harvey et al., 2007; Espie and Morin, 2003) , systematic reviews on treatment effectiveness (Eccleston et al., 2009; Williams et al., 2012; Morley et al., 1999) , and research on transdiagnostic processes maintaining these disorders Tang et al., 2007b Tang et al., ,c, 2010 Tang et al., , 2012c . Equal emphasis was given to pain and sleep. The 8 treatment components included (i) sleep psycho-education, (ii) stimulus control, (iii) sleep restriction, (iv) cognitive therapy for insomnia, (v) individual pain formation, (vi) goal setting & behavioural activation, (vii) reducing pain catastrophising & safety-seeking behaviour, and (viii) reversing mental defeat for the management of chronic pain. The intervention used in Pigeon et al. (2012) was much more extensive and contained 16 elements commonly seen in pain management and insomnia treatment packages. The intervention was delivered individually by psychologist over 10 weekly sessions. Specifically, the intervention included (i) pain psychophysiology education, (ii) relaxation training, (iii) pacing, (iv) painspecific cognitive therapy, (v) activity planning, (vi) problem-solving, (vii) communication skills, and (viii) flare-up planning and relapse prevention for the management of chronic pain; (ix) sleep education, (x) sleep restriction, (xii) stimulus control, (xiii) sleep hygiene, (xiv) sleep-specific cognitive therapy, (xv) relaxation training, and (xvi) relapse prevention for the management of insomnia. Similarly, the combined treatment in Vitiello et al. (2013) incorporated CBT-I components such as sleep hygiene education, stimulus control, sleep restriction and daily sleep monitoring into a standard programme of pain management with pain education, physical activation, goal setting, relaxation, activity pacing, guided imagery and cognitive restructuring. However, the treatment was more didactic in nature, delivered in classes of 5-12 patients over six weekly 90-minute sessions.
Despite these differences, both Tang et al. (2012a) and Pigeon et al. (2012) found their respective hybrid treatments produced significantly better results in not only sleep, but also mood, fatigue and pain-related outcomes compared to waitlist controls. Pitching against standard programmes of CBT for pain or insomnia per se, the hybrid intervention showed a huge advantage over CBT for pain on most outcomes and a small advantage over CBT for insomnia in reducing insomnia severity in chronic pain patients (Pigeon et al., 2012) . These preliminary findings were upheld in the multi-centre RCTs by Vitiello et al. (2013) , in which the hybrid treatment logged the best outcome in reducing insomnia severity compared to both the education-only control and the CBT for pain groups. Although pain severity and arthritis outcomes did not differ among the 3 treatment arms, a subsequent secondary analysis using data across all groups revealed that long-term (9-and 18-month) improvements on multiple measures of sleep, chronic pain, and fatigue were significantly predicted by short-term (2-month) improvements in sleep. These findings support the idea that sleep treatment can have a beneficial impact on pain and other aspects of wellbeing, even though these effects may take time to emerge.
Challenges and issues remained
It appears as though the hybrid treatment approach has clear potential for enhancing treatment effectiveness of existing pain management programmes. Further replications would, however, be required to demonstrate reliability and generalisability across different subgroups of pain patients (e.g., musculoskeletal versus neuropathic versus inflammatory pain; regional versus diffuse pain) and treatment contexts (e.g., primary versus secondary care). It would be also important to rule out that the better outcomes associated with hybrid treatment over standard pain or insomnia treatment was not merely an artefact of the longer treatment duration, extended treatment content, or other confounders, such as researchers' allegiance and enthusiasm, not controlled for in the aforementioned outcome studies.
Whilst additional help with sleep was something specifically requested by patients for improving their management of chronic pain (Breivik et al., 2006; Turk et al., 2008a; Casarett et al., 2001) , it is unclear if the treatment experience has been found positive and beneficial by this patient group. None of the previous trials on hybrid pain and sleep treatment was published with an accompanying treatment process evaluation. To inform patient-centred care, future studies should consider including qualitative analyses as such to shed light on the acceptability of the new treatment approach. Additionally, qualitative feedback from treatment providers would be useful in terms of informing the therapist training, treatment delivery and dissemination processes, all of which are yet to be refined at this infancy stage of treatment development. Practical questions like "who with what training should be delivering the treatment in what dosage, format, and sequence?" and "where should we situate the service within the existing clinical care pathway to achieve optimal long-term costeffectiveness?" need to be answered. Answers to these questions will have important implications for future research funding and service development.
Conclusion
The developing of a feasible hybrid treatment for pain and insomnia has taken advantage of the growing wealth of research evidence into the links and association between the two conditions (Smith and Haythornthwaite, 2004; Finan et al., 2013) . Given the equally fascinating links of pain with depression (Arnow et al., 2006; Knaster et al., 2012) , PTSD (Otis et al., 2003; Asmundson et al., 2002; Sharp and Harvey, 2001) , substance misuse (Turk et al., 2008b; Chou et al., 2009; Fishbain et al., 1992) , obesity (Janke et al., 2007; Okifuji and Hare, 2015; Shiri et al., 2010; Amy and Kozak, 2012) , to name but a few, the hybrid treatment approach could easily be adopted to provide more concentrated care in these areas depending on the patient's need. This is especially relevant considering that, with a more refined understanding of the connections between these oft-seen comorbidities, a modular treatment design could be engineered to expand the breadth and flexibility of clinical service and enhance patients' choice. The adoption of the hybrid treatment framework may even facilitate a more rapid transfer of theoretical and psychological treatment advances in the linked fields, stimulating innovations in the years to come.
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